Emergent Biosolutions
EBS
EBS
182 hedge funds and large institutions have $537M invested in Emergent Biosolutions in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 59 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 168 → 182 (+14)
4.5% more ownership
Funds ownership: 78.16% → 82.65% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
182
Holding in Top 10
2
Calls
$7.82M
Puts
$2.27M
Top Buyers
| 1 | +$6.74M | |
| 2 | +$4.65M | |
| 3 | +$4.31M | |
| 4 |
Jane Street
New York
|
+$4.24M |
| 5 |
HF
HRT Financial
New York
|
+$3.34M |
Top Sellers
| 1 | -$4.73M | |
| 2 | -$3.8M | |
| 3 | -$2.91M | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$2.41M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.87M |
